Your End-to-End Viral Gene Therapy Manufacturing Partner
Across our global network, multiple entry points offer maximum flexibility to efficiently serve our partners’ needs
Whether you choose full process development or enter the network through multi-candidate screening and feasibility assessment, we partner with you to bring late-phase manufacturing concepts to early-phase process design.
Our approach is to create simple, streamlined, modular paths that minimize risk and improve affordability, while platform analytics and processes minimize process development time. We also offer a more tailored approach in cases where an improvement in product quality or titer is required.
Industry-Relevant Viral Gene Therapy Offerings
Our experts work with you to develop a process that will be robust, scalable and ultimately have a line of sight to commercialization. With options to use a platform process or something more tailored to your molecule, we have a solution for your viral gene therapy needs.
Our analytical teams specialize in testing critical quality attributes of your product and phase appropriate validation of analytical methods.
Creating effective, scalable manufacturing strategies for our partners ensures that we provide a customized service on your path to commercialization.
